ArticleFundamental & clinical pharmacology2009

Benefit of therapeutic drug monitoring of protease inhibitors in HIV-infected patients depends on PI used in HAART regimen--ANRS 111 trial.

Xavier Duval et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.